Dosage Forms

Reshaping Dosage Forms

Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Frontrunners in Bispecific Antibodies

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

First Successful Efficacy Study Against Omicron With COVID-19 Vaccine

June 27, 2022

The Sanofi-GSK vaccine is the first candidate to demonstrate efficacy in a placebo-controlled trial with a high-Omicron environment.

Batavia Biosciences Increases Capacity for Viral Vectors and Vaccine R&D in the Netherlands

June 17, 2022

Batavia Biosciences is expanding its headquarters and R&D capabilities in its Netherlands facility.

FDA Approves GSK’s MMR Vaccine

June 08, 2022

FDA has approved GSK’s vaccine for the prevention of measles, mumps, and rubella in individuals 12 months of age and older.

Focusing on the Patient in Drug Development

June 03, 2022

Putting the patient at the forefront of drug development is essential, particularly to ensure medication compliance is optimized.

Dissolution Testing Sees Advances

June 01, 2022

Dissolution testing has seen recent trends that have led to increased data integrity solutions as well as an increase in biorelevant testing techniques.

Lubrizol Launches Apisolex Technology

May 26, 2022

Lubrizol has launched Apisolex technology to improve solubility and simplify the manufacturing of parenteral drug products.

Vaxzevria Gains Approval in EU as a Third Dose COVID-19 Booster in Adults

May 24, 2022

AstraZeneca's recombinant COVID-19 vaccine, originally invented by the University of Oxford, has been approved as a third dose booster vaccine in the EU.

EMA Recommends Approval of Niemann-Pick Disease Types A/B and B Therapy

May 24, 2022

EMA has recommended the marketing authorization of Xenpozyme (olipudase alfa) in the European Union.

Manufacturing OSD Forms: Key Trends Shaping the Industry

May 16, 2022

The latest manufacturing technologies are essential for helping pharmaceutical formulators meet up-and-coming trends in OSD treatments.

Don’t Gamble on Tablet Tooling Maintenance

May 16, 2022

By following some fundamental steps, manufacturers can optimize their tablet tooling maintenance and resulting productivity.